Pay in 4 interest-free payments of $5.97 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
Phase 2 trial data (Jastreboff et al., NEJM 2023) demonstrated average weight reductions of approximately 1724% over 48 weeks notably higher than currently approved GLP-1 receptor agonists such as semaglutide, though direct comparisons are limited by differences in trial populations and designs
Musculoskeletal symptoms: Joint pain (arthralgia), muscle aches, peripheral edema (mild swelling) [9]
Still, because NAD+ injections are a relatively novel therapy, patients should be monitored for any unexpected reactions
S2CID 265273574
Our B12 injections always use methylcobalamin
US$ 21.90
US$ 25.37
US$ 29.01
US$ 20.78
US$ 21.11
US$ 21.83
US$ 21.04
